USPTO trademark

MYARCIM

RegisteredUSPTOWord markClass 9Class 10Class 35Class 42+1

"MYARCIM" is a word mark owned by ONWARD Medical N.V., filed at the USPTO on November 11, 2022. It is registered and covers classes 9, 10, 35, 42 and 44.

Official USPTO record
MYARCIM trademark as filed
As filed with the USPTO
Status
Registered
Since April 9, 2024
Filed
November 11, 2022
Registered
April 9, 2024
Priority date
October 25, 2022
Claimed from European Union
Application no.
97673382
Registration no.
7350755
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns MYARCIM

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

ONWARD Medical N.V.

Eindhoven, Netherlands

52 trademarks in the portfolioView company

Representative

Laura K. Johnson

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Goods and services

What the mark covers

The products and services MYARCIM is filed for, grouped by Nice class.

  • Downloadable software applications for managing medical apparatus and instruments; Downloadable mobile apps for managing medical apparatus and instruments; Software as a medical device, namely, downloadable software for managing medical apparatus and instruments; These goods are specific to the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, physical therapy, and physical rehabilitation and in no way related to cancer medical research

  • Medical and veterinary apparatus and instruments for neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation; Medical and veterinary apparatus and instruments for the restoration, support, control and regulation of autonomic and sacral functions; Diagnostic examination and monitoring equipment used to measure, analyze, and monitor biometric data for use in treatment of patients in the neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation fields; Artificial spinal implants and prosthetic neural implants; Electric nerve stimulators; Electronic nerve stimulators; Nerve muscle stimulators; Transcutaneous electrical muscle stimulators; Electronic stimulators for neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation; Leads for use with implantable nerve stimulators; Medical apparatus and instruments for the treatments of patients with neuromotor impairment and/or neuropathies and/or paraplegia and/or locomotion disabilities or handicaps; Treadmills for medical use; Orthopedic and mobility aids, namely, walkers, canes for medical purposes; Medical supports for the body for general medical use for general use; Compression garments, chemically activated hot and/or cold body support compresses, compression socks; Bandages for supporting the human body

  • Computerized management of medical records and files; Retail services, namely, online ordering services, catalog ordering services, and through direct solicitation by distributors for medical and veterinary apparatuses and instruments; Wholesale services through direct solicitation by distributors for medical and veterinary apparatuses and instruments; These services are specific to the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, physical therapy, and physical rehabilitation and in no way related to cancer medical research

  • IT services for support in the use of medical apparatus and instruments, namely, 24/7 support desk services; Science and technology services in the nature of medical research and development of treatments in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, physical therapy, and physical rehabilitation; Testing, authentication and quality control for others of medical apparatus and instruments; Design services for medical apparatus and instruments; Medical research services; Natural science services in the nature of medical research; Clinical research in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, physical therapy, and physical rehabilitation; Biomedical research services; Medical and scientific research, namely, conducting clinical trials in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, physical therapy, and physical rehabilitation for others; Medical and scientific research, namely, conducting clinical trials for others in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, physical therapy, and physical rehabilitation; Engineering research; Software engineering; Mechanical engineering, especially medical engineering in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, physical therapy, and physical rehabilitation; These services are specific to the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, physical therapy, and physical rehabilitation and in no way related to cancer medical research

  • Medical rehabilitation services regarding the restoration, support, control and regulation of autonomic and sacral functions; Providing physical rehabilitation facilities; Providing neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation services; Physical therapy services; Development of individual physical rehabilitation programs; Provision of exercise facilities specifically for health rehabilitation services; Consulting services in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation services; Remote monitoring of medical data for medical diagnosis and treatment; Medical information; Medical assistance

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Registered-principal register
  2. Notice of registration confirmation emailed
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Electronic record review complete
  7. On hold - electronic record review required
  8. Approved for pub - principal register
  9. Teas/email correspondence entered
  10. Correspondence received in law office

10 earlier steps on the official record.

FAQ

About MYARCIM

Who owns the trademark "MYARCIM"?

The USPTO trademark "MYARCIM" (application 97673382) is owned by ONWARD Medical N.V.

What is the status of "MYARCIM"?

Its status at the USPTO is: registered.

When was "MYARCIM" registered?

It was registered on April 9, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MYARCIM and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2b19-ec70-71cf-be9d-fac78b883237
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b19-ec70-71cf-be9d-fac78b883237",
  "object": "trademark",
  "mark_text": "MYARCIM",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97673382",
  "filing_date": "2022-11-11",
  "nice_classes": [
    9,
    10,
    35,
    42,
    44
  ],
  "owners": [
    {
      "name": "ONWARD Medical N.V.",
      "entity_id": "ent_019eb70e-8170-71fa-9e1e-afe71b9910b0"
    }
  ]
}